Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.

Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.

PURPOSE:The aim of this study was to design a method of radionuclide for imaging and therapy of nasopharyngeal carcinoma (NPC) using the transferred human sodium/iodide symporter (hNIS) gene. METHODS:A stable NPC cell line expressing hNIS was established (CNE-2-hNIS). After 131I treatment, we detect...

Full description

Bibliographic Details
Main Authors:	Xing Zhong, Changzheng Shi, Jian Gong, Bin Guo, Mingzhu Li, Hao Xu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4304840?pdf=render

Similar Items

In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
by: Shuo Shi, et al.
Published: (2015-01-01)

Sodium iodide symporter-targeted gene therapy in glioblastoma
by: Juan Pablo Nicola, et al.
Published: (2023-03-01)

Tumor microenvironment affects exogenous sodium/iodide symporter expression
by: Fabio Castillo-Rivera, et al.
Published: (2021-01-01)

Expression of sodium-iodide symporter in thyroid gland tumors: immunohistochemical study
by: Bondarenko O.O., et al.
Published: (2009-01-01)

Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
by: Min Zhang, et al.
Published: (2014-01-01)

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
by: Rebekka Spellerberg, et al.
Published: (2022-12-01)

Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.
by: Zhi Liu, et al.
Published: (2012-01-01)

Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma
by: Hassan Rakhsh-Khorshid, et al.
Published: (2020-12-01)

In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs
by: Isabel Punzón, et al.
Published: (2020-06-01)

Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity
by: Liang Ji-An, et al.
Published: (2010-11-01)

Mechanisms of Sodium/Iodide Symporter-Mediated Mammary Gland Iodine Compensation during Lactation
by: Min Fu, et al.
Published: (2022-08-01)

Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells.
by: Cesidio Giuliani, et al.
Published: (2014-01-01)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
by: Taemoon Chung, et al.
Published: (2015-01-01)

Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice
by: Bryan Holvoet, et al.
Published: (2015-12-01)

High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
by: Dmitry Soloviev, et al.
Published: (2022-12-01)

The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.
by: James Ryan, et al.
Published: (2011-01-01)

Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
by: Jin Hee Lee, et al.
Published: (2022-07-01)

Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and Back
by: Byeong-Cheol Ahn
Published: (2012-01-01)

Effect of thyroid statuses on sodium/iodide symporter (<it>NIS</it>) gene expression in the extrathyroidal tissues in mice
by: Harun-Or-Rashid, et al.
Published: (2010-06-01)

Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes
by: Rebekka Spellerberg, et al.
Published: (2021-12-01)

A putative mechanism of the Sodium/Iodide Symporter regulation during repetitive administration of stable Iodide described by a Systems Biology approach
by: Cohen David, et al.
Published: (2019-01-01)

Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter
by: Xiao-Feng Gao, et al.
Published: (2014-02-01)

Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo
by: Piotr Dzien, et al.
Published: (2023-09-01)

HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
by: Wenwen Chai, et al.
Published: (2019-07-01)

Impact of Preoperative Detection of Sodium-Iodide Symporter Expression Level on Differentiated Thyroid Cancer (DTC) Prognosis
by: Marina Evgen'evna Boriskova, et al.
Published: (2015-10-01)

Cancer gene therapy: Prospects of using human sodium iodide symporter gene in non-thyroidal cancer
by: Shruti Dutta, et al.
Published: (2015-01-01)

In Vivo Scintigraphic Imaging of Antitumor Effects by Combined Radioiodine Therapy and Human Sodium Iodide Symporter Gene Immunotherapy
by: Yun Choi, et al.
Published: (2010-05-01)

Relationship between Apoptosis Imaging and Radioiodine Therapy in Tumor Cells with Different Sodium Iodide Symporter Gene Expression
by: Kyung Oh Jung, et al.
Published: (2015-01-01)

Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
by: Fang Lee, et al.
Published: (2022-03-01)

Adherens Junction Integrity Is a Critical Determinant of Sodium Iodide Symporter Residency at the Plasma Membrane of Thyroid Cells
by: Márcia Faria, et al.
Published: (2022-10-01)

Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
by: Seul-Gi Oh, et al.
Published: (2023-09-01)

The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus Pathogenesis
by: Svetlana Chefer, et al.
Published: (2018-12-01)

TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells.
by: Márcia Faria, et al.
Published: (2020-01-01)

Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
by: Dana Haddad, et al.
Published: (2012-01-01)

Theranostic studies of human sodium iodide symporter imaging and therapy using 188Re: a human glioma study in mice.
by: Rui Guo, et al.
Published: (2014-01-01)

Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma
by: Natalia Garcia, et al.
Published: (2023-12-01)

Exogenous Melatonin Protects against Oxidative Damage to Membrane Lipids Caused by Some Sodium/Iodide Symporter Inhibitors in the Thyroid
by: Aleksandra K. Gładysz, et al.
Published: (2023-08-01)

Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells.
by: Hae Won Kim, et al.
Published: (2013-01-01)

Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging.
by: Dominique N Price, et al.
Published: (2016-01-01)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
by: Hutzen Brian, et al.
Published: (2012-11-01)